Recently, the medical journal "The Lancet·Regional Health-Western Pacific Region" published online an article by the China-Japan Friendship Hospital, the World Health Organization Collaborative Center for Smoking Cessation and Respiratory Disease Prevention, the National Center for Respiratory Medicine, and the National Clinical Medicine for Respiratory Diseases. Research Center, Academician Wang Chen, Chinese Academy of Medical Sciences Institute of Respiratory Diseases, and Professor Xiao Dan's team completed "The Current Situation of Diagnosis and Treatment of Smoking Cessation in the Real World in China: Based on a Prospective, Multi-center China Smoking Cessation Cohort Study (CNTCCS)". This study comprehensively evaluates the current situation of smoking cessation diagnosis and treatment in the real world in my country, and plays a positive role in improving the construction of my country's clinical smoking cessation system and further improving the success rate of smoking cessation.
It is an indisputable medical fact that smoking is harmful to health. Tobacco kills more than 1 million people in our country every year because of its health hazards. In addition, about half of the current smokers in my country suffer from tobacco dependence, and the number of patients is about 183.5 million. Smoking cessation is recognized as the most effective and cost-effective strategy for reducing the risk of smoking-related disease and premature death. Quitting smoking before the age of 40 reduces the risk of death from smoking-related diseases by 90%, compared with continuing smokers. Additionally, quitting smoking can improve quality of life and extend lifespan. In order to further improve my country's clinical smoking cessation system, academician Wang Chen and Professor Xiao Dan led the "China Smoking Cessation Cohort Study" based on the current situation of clinical smoking cessation in my country and the problems to be solved urgently.
Based on the "China Smoking Cessation Cohort Study", 27 cooperative units were established in all seven geographical regions of East my country, South China, North China, Central China, Southwest China, Northwest China, and Northeast China, and 2943 representative cases who were willing to quit smoking were recruited Smokers, observed their smoking cessation and followed up for a period of 3 months. The study found that: 75.8% of the subjects suffered from tobacco dependence; 32.8% used bupropion hydrochloride sustained-release tablets, 31.8% used psychological and behavioral interventions, 26.4% used varenicline tartrate, and 4.6% used acupuncture 4.4% used nicotine replacement therapy; after 3 months of treatment and 3 months of follow-up, 21.74% of the subjects successfully quit smoking; there are some differences in the curative effect of smoking cessation in different regions, and the higher the rate of smoking cessation drug use The higher the area, the higher the success rate of smoking cessation.
The research results show that there is still a lot of room for improvement in my country's clinical smoking cessation system. In particular, nearly 80% of smoking cessation outpatients suffer from tobacco dependence. Low. For this reason, Academician Wang Chen emphasized: "On the one hand, smokers should be made aware that tobacco dependence is a lethal, chronic, highly recurrent, and addictive disease, and it is a risk factor for chronic non-communicable diseases in the future." The culprit; on the other hand, similar to the "promoting prevention, diagnosis, control and treatment" of chronic non-communicable diseases, the government, hospitals, professional institutions, communities, etc. should provide support to manage tobacco dependence as a major chronic disease, especially including Routine clinical diagnosis and treatment work, and improve the relevant system."
Another important finding of this study is that the use of smoking cessation drugs is far below the requirements of clinical smoking cessation guidelines, and the higher the rate of smoking cessation drug use, the higher the success rate of smoking cessation. Professor Xiao Dan appealed that "smoking cessation drugs can significantly improve the success rate of smoking cessation, the accessibility and affordability of smoking cessation drugs should be improved in my country, and smoking cessation and tobacco dependence treatment should be included in the scope of medical insurance."
微信扫一扫打赏
